AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs
In This Article:
AbbVie stock inched higher Friday after the pharma titan hiked its outlook on the back of strength from its immunology powerhouses.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
AbbVie stock inched higher Friday after the pharma titan hiked its outlook on the back of strength from its immunology powerhouses.